SCHEMBL4757089

SCHEMBL4757089

Nc1ncc(C2CC2)c(N2CCN(C(=O)O)CC2)c1[N+](=O)[O-]

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.34
NPC1 O15118 1/20 0.34
NEK2 P51955 2/20 0.34
ATR Q13535 2/20 0.33
RPS6KB1 P23443 2/20 0.33
CHRM3 P20309 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
GRM5 P41594 1/20 0.31
CDK2 P24941 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
POLB P06746 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757090 1.00 HTT (0.34) HTTNPC1NEK2ATRRPS6KB1
SCHEMBL13985469 0.84 MAPT (0.47) MAPT
SCHEMBL4754675 0.82 MAPT (0.40) HTTNPC1RPS6KB1KMT2ACYP3A4
SCHEMBL209374 0.82 ABL1 (0.39) HTTNPC1RPS6KB1GRM5MEN1
SCHEMBL209373 0.82 ABL1 (0.39) HTTNPC1RPS6KB1GRM5MEN1
SCHEMBL4755250 0.79 LMNA (0.39) HTTATRRPS6KB1GRM5MEN1
SCHEMBL4755253 0.79 LMNA (0.39) HTTATRRPS6KB1GRM5MEN1
SCHEMBL13985740 0.74 LMNA (0.57) KMT2ASMN1; SMN2
SCHEMBL15972434 0.69 SMN1; SMN2 (0.41) HTTNPC1MEN1KMT2AL3MBTL1
SCHEMBL15972432 0.69 SMN1; SMN2 (0.41) HTTNPC1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009001021-A1 IMIDAZOPYRIDINE DERIVATIVES USEFUL AS ENZYME INHIBITORS FOR THE TREATMENT OF CELL PROLIFERATIVE AND AUTOIMMUNE DISEASES CHROMA THERAPEUTICS LTD. (GB) 2008-12-31 WO disclosed